XTL BIOPHARMACEUTICALS LTD. Insurance Expense
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Insurance Expense of $202.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-22.
Discontinued › Operating Expenses
ifrs-full:InsuranceExpense · last filed 2023-03-22
| Period end | Insurance Expense 12 month |
|---|---|
| 2022-12-31 | $202.00K 20-F · filed 2023-03-22 |
| 2021-12-31 | $229.00K 20-F · filed 2023-03-22 |
| 2020-12-31 | $151.00K 20-F · filed 2023-03-22 |
| 2019-12-31 | $106.00K 20-F · filed 2022-03-30 |
| 2018-12-31 | $48.00K 20-F/A · filed 2021-05-19 |
| 2017-12-31 | $34.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | $48.00K 20-F · filed 2019-03-11 |
| 2015-12-31 | $62.00K 20-F · filed 2018-03-15 |